1. Intrapartum antibiotic use is associated with higher child body mass index (BMI) z-score at 4 years of age.
- Author
-
Cho NA, Giesbrecht GF, Dewey D, and Reimer RA
- Subjects
- Humans, Female, Pregnancy, Child, Preschool, Prospective Studies, Alberta epidemiology, Male, Prenatal Exposure Delayed Effects, Adult, Body Mass Index, Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents administration & dosage, Pediatric Obesity
- Abstract
Early life antibiotic exposure may increase obesity risk. We investigated if prenatal, intrapartum, or childhood antibiotic use is associated with child zBMI score at 4 yrs of age. We included data from the Alberta Pregnancy Outcomes and Nutrition (APrON) study, a prospective cohort study, on maternal and child antibiotic exposure and clinic measures of height and weight at age 4 (n = 408). Prenatal and childhood antibiotic exposure was not associated with zBMI score. Maternal intrapartum antibiotic exposure was associated with a zBMI score increase of 0.12 (95 % CI; 0.04, 0.46) in children at 4 years of age compared to non-exposure intrapartum., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Raylene Reimer and Gerald Giesbrecht report financial support was provided by the Canadian Institutes of Health Research. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Competing interests The authors declare no conflicts of interest., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF